ELTD1, an effective anti-angiogenic target for gliomas: preclinical assessment in mouse GL261 and human G55 xenograft glioma models.
Ziegler J, Pody R, Coutinho de Souza P, Evans B, Saunders D, Smith N, Mallory S, Njoku C, Dong Y, Chen H, Dong J, Lerner M, Mian O, Tummala S, Battiste J, Fung KM, Wren JD, Towner RA.
Ziegler J, et al. Among authors: fung km.
Neuro Oncol. 2017 Feb 1;19(2):175-185. doi: 10.1093/neuonc/now147.
Neuro Oncol. 2017.
PMID: 27416955
Free PMC article.